Bexxar Medication Information
Bexxar® (tositumomab) is a medicine prescribed to treat certain types of non-Hodgkin's lymphoma in adults. It is approved for use in people whose cancer has come back (relapsed) or is not responding to other treatment (refractory). This drug comes as an intravenous (IV) injection that is administered by your healthcare provider. You will receive two doses in one day, followed by two more doses the same day of the week one to two weeks later.
This medicine works by binding to proteins on certain cells, marking them for destruction by the immune system. Bexxar is also attached to a radioactive element, which emits radiation to kill surrounding cancer cells.
Before starting treatment with Bexxar, make sure to review the medication's safety information with your healthcare provider. For example, you may not be able to receive Bexxar if you have certain allergies, are taking certain other medications, or are pregnant or breastfeeding.
(Click Bexxar for more information on this chemotherapy medication. This resource offers a complete overview on this drug, including details on how it performed in clinical trials, possible side effects, and more.)